[1]
|
Nobel, T. and Molena, D. (2019) Surgical Principles for Optimal Treatment of Esophagogastric Junction Adenocarci-noma. Annals of Gastroenterological Surgery, 3, 390-395. https://doi.org/10.1002/ags3.12268
|
[2]
|
Stange, D.E., Weitz, J. and Welsch, T. (2017) Chirurgische Therapie von Adenokarzinomen des gastroösophagealen Übergangs und des Magens. Gastroenterologe, 12, 401-406. https://doi.org/10.1007/s11377-017-0190-0
|
[3]
|
Amenabar, A., Hoppo, T. and Jobe, B.A. (2013) Surgical Management of Gastroesophageal Junction Tumors. Seminars in Radiation Oncology, 23, 16-23. https://doi.org/10.1016/j.semradonc.2012.09.002
|
[4]
|
Jung, M.K., Schmidt, T., Chon, S.H, et al. (2020) Current Surgical Treatment Standards for Esophageal and Esophagogastric Junction Cancer. Annals of the New York Academy of Sciences, 1482, 77-84.
https://doi.org/10.1111/nyas.14454
|
[5]
|
Birla, R., Gandea, C., Hoara, P., et al. (2018) Clinical and Therapeutic Implications of the 8th Edition TNM Classification of Adenocarcinomas of the Esophagogastric Junction. Chirurgia, 113, 747-757.
https://doi.org/10.21614/chirurgia.113.6.747
|
[6]
|
Mazer, L.M. and Poultsides, G.A. (2019) What Is the Best Op-eration for Proximal Gastric Cancer and Distal Esophageal Cancer? Surgical Clinics of North America, 99, 457-469. https://doi.org/10.1016/j.suc.2019.02.003
|
[7]
|
Wallner, B. (2009) Endoscopically Defined Gastroesophageal Junction Coincides with the Anatomical Gastroesophageal Junction. Surgical Endoscopy, 23, 2155-2158. https://doi.org/10.1007/s00464-008-0238-9
|
[8]
|
Coit, D. (2013) Surgical Approaches to Invasive Adenocarcinoma of the Gastroesophageal Junction. American Society of Clinical Oncology Educational Book, 33, e144-e150. https://doi.org/10.14694/EdBook_AM.2013.33.e144
|
[9]
|
Fiocca, R., Mastracci, L., Lugaresi, M., et al. (2021) The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma. Cancers (Basel), 13, 5211. https://doi.org/10.3390/cancers13205211
|
[10]
|
Ziyu, Z., Yimin, W., Fengke, L., et al. (2019) Comparison of Clinicopathological Features and Prognosis between Adenocarcinoma of Esophagogastric Junction and Adenocarcinoma of Gastric Antrum. Chinese Journal of Gastrointestinal Surgery, 22, 149-155.
|
[11]
|
Cao, J., Yang, T., Wang, G., et al. (2018) Analysis of the Clinicopathological Features and Prognostic Factors in 734 Cases of Chinese Hui and Han Patients with Adenocarcinoma of the Esophagogastric Junction. Surgical Oncology, 27, 556-562. https://doi.org/10.1016/j.suronc.2018.07.008
|
[12]
|
Zhou, Z., Zhang, H., Xu, Z., Li, W., Dang, C. and Song, Y. (2015) Nomogram Predicted Survival of Patients with Adenocarcinoma of Esophagogastric Junction. World Journal of Surgical Oncology, 13, 197.
https://doi.org/10.1186/s12957-015-0613-7
|
[13]
|
Zhang, H., Zhang, W.J., Peng, D.F. and Zhu, J.H. (2018) Short-Term Postoperative Complications and Prognostic Factors in Patients with Adenocarcinoma of the Esophagogastric Junction. Thoracic Cancer, 9, 1018-1025.
https://doi.org/10.1111/1759-7714.12780
|
[14]
|
Chen, X.D., He, F.Q., Chen, M. and Zhao, F.Z. (2020) Incidence of Lymph Node Metastasis at Each Station in Siewert Types II/III Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta-Analysis. Surgical Oncology, 35, 62-70. https://doi.org/10.1016/j.suronc.2020.08.001
|
[15]
|
Anderegg, M.C.J., Lagarde, S.M., Jagadesham, V.P., et al. (2016) Prognostic Significance of the Location of Lymph Node Metastases in Patients with Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction. Annals of Surgery, 264, 847-853. https://doi.org/10.1097/SLA.0000000000001767
|
[16]
|
Okholm, C., Svendsen, L.B. and Achiam, M.P. (2014) Status and Prognosis of Lymph Node Metastasis in Patients with Cardia Cancer—A Systematic Review. Surgical On-cology, 23, 140-146.
https://doi.org/10.1016/j.suronc.2014.06.001
|
[17]
|
Reeh, M., Mina, S., Bockhorn, M., et al. (2012) Staging and Outcome Depending on Surgical Treatment in Adenocarcinomas of the Oesophagogastric Junction. British Journal of Surgery, 99, 1406-1414. https://doi.org/10.1002/bjs.8884
|
[18]
|
Di Leo, A. and Zanoni, A. (2017) Siewert III Ad-enocarcinoma: Treatment Update. Updates in Surgery, 69, 319-325.
https://doi.org/10.1007/s13304-017-0429-9
|
[19]
|
Ustaalioǧlu, B.B.Ö., Tilki, M., Sürmelioǧlu, A., et al. (2017) The Clinicopathologic Characteristics and Prognostic Factors of Gastroesophageal Junction Tumors According to Siewert Classification. Turkish Journal of Surgery, 33, 18-24. https://doi.org/10.5152/UCD.2017.3379
|
[20]
|
Yang, Z.-F., Wu, D.-Q., Wang, J.-J., et al. (2018) Surgical Approach for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: Transthoracic or Transabdominal?—A Single-Center Retrospective Study. Annals of Translational Medicine, 6, 450-450. https://doi.org/10.21037/atm.2018.10.66
|
[21]
|
Tosolini, C., Reim, D., Schirren, R., Feith, M., Friess, H. and Novotny, A.R. (2019) Influence of the Surgical Technique on Survival in the Treatment of Carcinomas of the True Cardia (Siewert Type II)—Right Thoracoabdominal vs. Transhiatal-Abdominal Approach. European Journal of Surgical Oncology, 45, 416-424.
https://doi.org/10.1016/j.ejso.2018.09.017
|
[22]
|
Kim, B.J., Chiang, Y.J., Das, P., et al. (2020) Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States. Journal of Clinical Medicine, 9, 3495. https://doi.org/10.3390/jcm9113495
|
[23]
|
Kamarajah, S.K., Navidi, M., Wahed, S., et al. (2020) Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction. Annals of Surgeryical Oncology, 27, 3182-3192.
https://doi.org/10.1245/s10434-020-08358-0
|
[24]
|
Orditura, M., Galizia, G., Di, Martino, N., et al. (2014) Effect of Preoperative Chemoradiotherapy on Outcome of Patients with Locally Advanced Esophagogastric Junction Adeno-carcinoma—A Pilot Study. Current Oncology, 21, 125-133. https://doi.org/10.3747/co.21.1570
|
[25]
|
Thrift, A.P., Nagle, C.M., Fahey, P.P., Smithers, B.M., Watson, D.I. and Whiteman, D.C. (2012) Predictors of Survival among Pa-tients Diagnosed with Adenocarcinoma of the Esophagus and Gastroesophageal Junction. Cancer Causes & Control, 23, 555-564. https://doi.org/10.1007/s10552-012-9913-1
|
[26]
|
Tang, W., Liu, J., Zhong, Z., Qiu, H. and Kang, M. (2019) Association of Metabolism-Related Genes Polymorphisms with Adenocarcinoma of the Oesophagogastric Junction: Evidence from 2261 Subjects. Journal of Cellular Biochemistry, 120, 18689-18701. https://doi.org/10.1002/jcb.29167
|